Combined Therapy of 532-nm KTP and Microsecond 1064-nm Nd:YAG Laser for Rosacea (NCT07250165) | Clinical Trial Compass
CompletedNot Applicable
Combined Therapy of 532-nm KTP and Microsecond 1064-nm Nd:YAG Laser for Rosacea
China15 participantsStarted 2024-08-10
Plain-language summary
Rosacea remains a therapeutically challenging, chronic facial dermatosis whose central feature-persistent erythema-often resists topical and systemic agents. In this study we evaluated, for the first time, the simultaneous use of a 532-nm potassium titanyl phosphate (KTP) laser and a microsecond-pulsed 1064-nm Nd:YAG laser as a safe alternative.
Who can participate
Age range
18 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Participants aged between 18 and 65 years, without cognitive impairments, and of any gender
* Patients must meet the 2017 rosacea diagnostic criteria updated by the National Rosacea Society Expert Committee
* The severity of rosacea must be scored at least 2 points on the Clinician's Erythema Assessment (CEA) scale.
Exclusion Criteria:
* if they had undergone any treatments that could influence the prognosis of rosacea within the preceding 8 weeks
* if they had taken photosensitizing or phototoxic medications within the same period
* the presence of other facial conditions that might confound the efficacy assessment
* participation in any drug clinical trial as a subject within the last month
* the presence of severe concurrent diseases
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
CEA scores
Timeframe: Baseline to Week 9
2
CEA success
Timeframe: Baseline to Week 9
Trial details
NCT IDNCT07250165
SponsorSecond Affiliated Hospital, School of Medicine, Zhejiang University